Table 1.

Clinical and laboratory parameters in the study cohort

S.No.	Age (in years) At diagnosis	Sex	Hb (g/dL)	Retic count (%)	G6PD Values$ (U/g Hb)	LDH (U/L)	History of Hematuria	Coexisting clinical condition
1*	6	Male	7.6	16.68	1.1	3900	Present	None
2*	2	Male	TX	TX	3.0	942	Present	None
3*	1	Male	7.9	16.25	< 0.2	7156	NA	None
4	3	Female	5	NA	5.1	5620	Present	Cold Agglutinin Disease
5	16	Male	8.9	3.53	< 2.0	340	Present	Beta Thalassemia Trait
6	10	Female	11.2	NA	< 2.1	NA	Absent	Beta Thalassemia Trait
7	1.5	Male	3.5	NA	1.7	2221	NA	None
8	0.8	Male	5.3	12	< 2.1	752	NA	Neonatal Hyperbilirubinemia
9	2	Male	3.7	NA	< 2.1	NA	Present	None
10	0.8	Male	5.6	12.9	< 2.1	648	NA	Neonatal Hyperbilirubinemia
11	2	Male	2.8	NA	4.7	NA	Present	Chemical Ingestion (Naphthalene Balls)
12	29	Female	10.1	1.33	< 2.1	650	NA	Iron Deficiency Anemia + Ectopic gestation
13	7	Male	TX	10.79	NA	TX	Present	None
14	2	Male	8.9	4.16	< 2.1	743	NA	Homozygous Sickle Cell Disease
15	3	Male	NA	NA	< 2.1	NA	NA	NA
16	13	Female	NA	NA	< 2.1	NA	NA	NA
17	4	Male	NA	NA	0.5	NA	Absent	Neonatal Hyperbilirubinemia
18*	10	Male	8	NA	0.3	NA	Absent	None
19	42	Male	NA	NA	0.23	NA	NA	Neonatal Hyperbilirubinemia
20	6	Male	NA	NA	1.3	NA	NA	None
21	18	Male	10.7	NA	0.6	NA	NA	None
22#	8	Male	9.2	0.16	6.3	2614	NA	Parvo virus B19 induced pure red cell aplasia
23#	0.6	Male	6.1	8.86	5.5	1142	Absent	Hereditary spherocytosis
24#	23	Female	5.4	13.59	5.8	1085	Present	Autoimmune hemolytic anemia

^*Patients with Novel variants

^#Patients negative for G6PD mutations

^$Biological Reference Range for G6PD is > 6.5 U/g Hb. TX transfused recently

NA not available, Hb Haemoglobin, LDH lactate dehydrogenase. Patients 1 and 3 were from the same family